Evaluation of dynamic thiol-disulfide homeostasis and ischemia-modified albumin levels in patients with chronic lymphocytic leukemia
Huseyin Erdal, Rafiye Ciftciler, Sibel Cigdem Tuncer, Oguzhan Özcan
DOI: 10.1136/jim-2022-002568 Published 29 August 2022
Huseyin Erdal
1Medical Genetics, Aksaray University, Aksaray, Turkey
Rafiye Ciftciler
2Hematology, Aksaray University, Aksaray, Turkey
Sibel Cigdem Tuncer
3Biochemistry, Aksaray University, Aksaray, Turkey
Oguzhan Özcan
4Biochemistry, Hatay Mustafa Kemal University, Hatay, Turkey

Submit a Response to This Article
No eLetters have been published for this article.
Evaluation of dynamic thiol-disulfide homeostasis and ischemia-modified albumin levels in patients with chronic lymphocytic leukemia
Huseyin Erdal, Rafiye Ciftciler, Sibel Cigdem Tuncer, Oguzhan Özcan
Journal of Investigative Medicine Aug 2022, jim-2022-002568; DOI: 10.1136/jim-2022-002568

Evaluation of dynamic thiol-disulfide homeostasis and ischemia-modified albumin levels in patients with chronic lymphocytic leukemia
Huseyin Erdal, Rafiye Ciftciler, Sibel Cigdem Tuncer, Oguzhan Özcan
Journal of Investigative Medicine Aug 2022, jim-2022-002568; DOI: 10.1136/jim-2022-002568